Key result
ML-driven QSAR models identify structural elements to optimize atypical DAT inhibitors with reduced hERG affinity.
Why the study?
When developing atypical DAT inhibitors for psychostimulant use disorders, avoiding off-target hERG potassium channel blockade is necessary to prevent potentially lethal ventricular tachycardia.
A combined machine learning and molecular modeling approach successfully established a counter-screening platform to optimize atypical DAT inhibitors while minimizing hERG-related cardiotoxicity.
Answers are grounded in this paper and cite their sources.
May inform preclinical DAT inhibitor optimization to limit hERG risk; leaves open clinical translation.
Psychostimulant drugs, such as cocaine, inhibit dopamine reuptake via blockading the dopamine transporter (DAT), which is the primary mechanism underpinning their abuse. Atypical DAT inhibitors are dissimilar to cocaine and can block cocaine- or methamphetamine-induced behaviors, supporting their development as part of a treatment regimen for psychostimulant use disorders. When developing these atypical DAT inhibitors as medications, it is necessary to avoid off-target binding that can produce unwanted side effects or toxicities. In particular, the blockade of a potassium channel, human ether-a-go-go (hERG), can lead to potentially lethal ventricular tachycardia. In this study, we established a counter screening platform for DAT and against hERG binding by combining machine learning-based quantitative structure–activity relationship (QSAR) modeling, experimental validation, and molecular modeling and simulations. Our results show that the available data are adequate to establish robust QSAR models, as validated by chemical synthesis and pharmacological evaluation of a validation set of DAT inhibitors. Furthermore, the QSAR models based on subsets of the data according to experimental approaches used have predictive power as well, which opens the door to target specific functional states of a protein. Complementarily, our molecular modeling and simulations identified the structural elements responsible for a pair of DAT inhibitors having opposite binding affinity trends at DAT and hERG, which can be leveraged for rational optimization of lead atypical DAT inhibitors with desired pharmacological properties.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2021) studied Psychostimulant use disorders. Machine learning and molecular modeling was evaluated on DAT and hERG binding affinities. A combined machine learning and molecular modeling approach established robust QSAR models to identify structural elements for optimizing atypical DAT inhibitors with reduced hERG affinity.
Synapse has enriched 10 related papers. Consider them for comparative context: